Ultrasound and Infertility, 89-124, 2020
Abstract not indexed. Read at source
Topics
ultrasound follicular growth monitoring ovulation detection, sonographic ovulation tracking spontaneous stimulated cycles, follicle development ultrasound infertility evaluation, Kurjak Jurkovic ultrasound follicular monitoring, ovarian stimulation cycle ultrasound follicle measurement, transvaginal ultrasound folliculometry ovulation prediction, serial ultrasound monitoring dominant follicle growth, ovulation induction follicle tracking ultrasonography, natural cycle follicular development ultrasound assessment
DOI 10.1201/9781003068204-4 10.1201/9781003068204-4
Cite this article
Kurjak, A., & Jurkovic, D. (2020). Ultrasonic Monitoring of Follicular Growth and Ovulation in Spontaneous and Stimulated Cycles. Ultrasound and Infertility, 89-124. https://doi.org/10.1201/9781003068204-4
Kurjak A, Jurkovic D. Ultrasonic Monitoring of Follicular Growth and Ovulation in Spontaneous and Stimulated Cycles. Ultrasound and Infertility. 2020:89-124. doi:10.1201/9781003068204-4
Kurjak, Asim, and Davor Jurkovic. "Ultrasonic Monitoring of Follicular Growth and Ovulation in Spontaneous and Stimulated Cycles." Ultrasound and Infertility, 2020, pp. 89-124.
Related articles
InfertilityLuteinized Unruptured FollicleGonadotropin TherapyFollicular Monitoring
Comparison of various therapies for the luteinized unruptured follicle syndrome
Check JH et al., 1992·Int J Fertil
A study was initiated to evaluate the prevalence of the luteinized unruptured follicle (LUF) syndrome in a group of 355 women with infertility. The diagnosis was established by carefully observing daily sonograms along with measuring estradiol, progesterone, and luteinizing hormone (LH) levels. Two distinct types of mature follicle LUF, in which release of an ovum was not demonstrated after a follicle attained maturity (serum estradiol reached 200 pg/mL while serum progesterone remained less than 2.5 ng/mL), versus premature luteinization LUF, where the serum progesterone increased above 2.5 ng/mL before follicular maturation was attained. The use of either hCG alone or hCG in combination with hMG in a single injection at the time of follicular maturation successfully corrected mature follicle LUF in 21 of 46 patients (46%), whereas ovulation-inducing drugs plus hCG or hCG and hMG corrected LUF in 24 of 25 patients (96%). Clomiphene citrate proved inferior to hMG in that it corrected LUF in 3 of 25 patients (12%) versus 12 of 22 patients (95%) who had undergone hMG therapy. Thus, hMG-hCG therapy is the most efficacious for mature follicle LUF, but because release can occur spontaneously on occasion by an appropriately timed single gonadotropin injection, one could offer the less costly options first. For premature luteinization, speeding up follicular maturation with gonadotropin therapy is effective. Upon failure of this technique, the more costly endogenous gonadotropin suppression followed by hMG can be employed.
InfertilityLuteinized Unruptured Follicle SyndromeFollicular MonitoringLUF Syndrome
LUF-syndrome: recent findings
Audebert A, 1990·J Gynecol Obstet Biol Reprod (Paris)
Luteinization of a follicle without its rupture and without the oocyte being expelled which is also called the LUF-syndrome by English speaking authors is one of a number of functional abnormalities that can occur to the follicle in the ovary and is diagnosed by ultrasound methods. It is one that has been known for quite a long time. Many publications have appeared since 1978 to describe this syndrome, which all the same is still very controversial. One has learnt how to diagnose it fairly well. One knows more about its physiopathogenesis and how often it occurs. This seems to be more often when there is pelvic endometriosis or so-called unexplained infertility. What is more difficult however is to find out how important it is as a cause of lowered fertility, and it is also it just happens occasionally or is a true syndrome? It is still not possible today to give a definite answer to this question because of reasons of methodology. Finally, as far as treatment goes, even if the facts about its pathogeneiity have been found out and should be able to help decide on a logical treatment there have been no controlled studies to find out whether the treatment works.
DiagnosticsFollicular MonitoringImaging TechniquesTransvaginal Sonography
Endovaginal and transabdominal sonography of ovarian follicles
Andreotti RF et al., 1989·J Ultrasound Med
Endovaginal and transabdominal sonography (EVS and TAS, respectively) are effective methods for monitoring ovarian follicular development. Our study evaluates both modalities by subjective comparisons and objective correlations with serum estradiol levels. In 21 of 41 studies, TVS showed more follicles over 1 cm than did TAS. The same number was seen by both in 17 studies and more by TAS in only 3 studies. Margins of the follicles were sharply defined in 37 of 41 EVS studies (90%) but only in 18 of 41 TAS studies (41%). In each of the 4 cases in which follicles were not sharply defined by EVS the ovaries were located high in the pelvis. In 29 sonographic studies, there were corresponding estradiol levels. The number and size of dominant follicles correlated well with estradiol levels (r = .9074) for EVS but less so (r = .3816) for TAS. EVS has several advantages when monitoring follicular development.
Menstrual CycleLuteinized Unruptured FollicleAnovulationFollicular Monitoring
Incidence of the luteinized unruptured follicle phenomenon in cycling women
Kerin JF et al., 1983·Fertil Steril
A prospective study is presented in order to determine the frequency of the luteinized unruptured follicle (LUF) in a population of 66 regularly cycling women. They were monitored by daily ultrasound for a total of 183 cycles, and the LUF was detected in 9 cycles, giving an incidence of 4.9%. The results of daily changes of luteinizing hormone, estradiol, and progesterone provide support for the thesis that the LUF behaves steroidogenically as a corpus luteum and that the luteal phase duration is normal. Continued monitoring in 35 cycles revealed a recurrence in only one case during a fourth subsequent cycle. Thus, the findings indicate that the LUF is a sporadic and infrequent phenomenon. It is therefore an uncommon cause of infertile cycles in potentially fertile women and represents a biologic variable rather than a syndrome. Based on ultrasonic and endocrine observations, a mechanism is proposed for the resolution of the LUF.